RadNet, Inc. (RDNT) delivered impressive third-quarter 2024 results, exceeding revenue estimates and raising its guidance. The company’s Digital Health segment, fueled by the success of its AI-powered breast cancer screening program, saw significant growth. RadNet’s strong financial performance and positive business trends have driven a surge in its stock price.